<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1200618</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1200618</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Human epidermal keratinocytes and human dermal fibroblasts interactions seeded on gelatin hydrogel for future application in skin <italic>in vitro</italic> 3-dimensional model</article-title>
<alt-title alt-title-type="left-running-head">Tahri et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1200618">10.3389/fbioe.2023.1200618</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tahri</surname>
<given-names>Safa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2273529/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maarof</surname>
<given-names>Manira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1729728/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masri</surname>
<given-names>Syafira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Che Man</surname>
<given-names>Rohaina</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masmoudi</surname>
<given-names>Hatem</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fauzi</surname>
<given-names>Mh Busra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1279981/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centre for Tissue Engineering and Regenerative Medicine</institution>, <institution>Faculty of Medicine</institution>, <institution>Universiti Kebangsaan Malaysia</institution>, <addr-line>Kuala Lumpur</addr-line>, <country>Malaysia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Research Laboratory LR12SP18 &#x201c;Autoimmunity, Cancer, and Immunogenetics&#x201d;</institution>, <institution>University Hospital Habib Bourguiba</institution>, <addr-line>Sfax</addr-line>, <country>Tunisia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Pathology Department</institution>, <institution>Faculty of Medicine</institution>, <institution>Universiti Kebangsaan Malaysia</institution>, <addr-line>Kuala Lumpur</addr-line>, <country>Malaysia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2026713/overview">Behnam Akhavan</ext-link>, The University of Newcastle, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2088355/overview">Annachiara Scalzone</ext-link>, Center for Advanced Biomaterials for Healthcare (IIT), Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1683168/overview">Dana Akilbekova</ext-link>, Nazarbayev University, Kazakhstan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Mh Busra Fauzi, <email>fauzibusra@ukm.edu.my</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1200618</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Tahri, Maarof, Masri, Che Man, Masmoudi and Fauzi.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Tahri, Maarof, Masri, Che Man, Masmoudi and Fauzi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> Plenty of biomaterials have been studied for their application in skin tissue engineering. Currently, gelatin-hydrogel is used to support three-dimensional (3D) skin <italic>in vitro</italic> models. However, mimicking the human body conditions and properties remains a challenge and gelatin-hydrogels have low mechanical properties and undergo rapid degradation rendering them not suitable for 3D <italic>in vitro</italic> cell culture. Nevertheless, changing the concentration of hydrogels could overcome this issue. Thus, we aim to investigate the potential of gelatin hydrogel with different concentrations crosslinked with genipin to promote human epidermal keratinocytes and human dermal fibroblasts culture to develop a 3D-<italic>in vitro</italic> skin model replacing animal models.</p>
<p>
<bold>Methods:</bold> Briefly, the composite gelatin hydrogels were fabricated using different concentrations as follows 3%, 5%, 8%, and 10% crosslinked with 0.1% genipin or non-crosslinked. Both physical and chemical properties were evaluated.</p>
<p>
<bold>Results and discussion:</bold> The crosslinked scaffolds showed better properties, including porosity and hydrophilicity, and genipin was found to enhance the physical properties. Furthermore, no alteration was prominent in both formulations of CL_GEL 5% and CL_GEL8% after genipin modification. The biocompatibility assays showed that all groups promoted cell attachment, cell viability, and cell migration except for the CL_GEL10% group. The CL_GEL5% and CL_GEL8% groups were selected to develop a bi-layer 3D-<italic>in vitro</italic> skin model. The immunohistochemistry (IHC) and hematoxylin and eosin staining (H&#x26;E) were performed on day 7, 14, and 21 to evaluate the reepithelization of the skin constructs. However, despite satisfactory biocompatibility properties, neither of the selected formulations, CL_GEL 5% and CL_GEL 8%, proved adequate for creating a bi-layer 3D <italic>in-vitro</italic> skin model. While this study provides valuable insights into the potential of gelatin hydrogels, further research is needed to address the challenges associated with their use in developing 3D skin models for testing and biomedical applications.</p>
</abstract>
<kwd-group>
<kwd>gelatin hydrogel</kwd>
<kwd>3D <italic>in vitro</italic> skin model</kwd>
<kwd>genipin</kwd>
<kwd>keratinocytes</kwd>
<kwd>fibroblasts</kwd>
<kwd>biomaterial</kwd>
</kwd-group>
<contract-num rid="cn001">FF-2021-491</contract-num>
<contract-sponsor id="cn001">Universiti Kebangsaan Malaysia<named-content content-type="fundref-id">10.13039/501100004515</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Tissue Engineering and Regenerative Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Tissue engineering is defined as a new branch of knowledge that combines technologies from different research areas including biology, chemistry, engineering, medicine, pharmacy, and material science (<xref ref-type="bibr" rid="B3">Bas et al., 2021</xref>). In addition to the potential to solve the current health issue of organ and tissue failure, this multidisciplinary field can provide advanced <italic>in vitro</italic> model systems. Indeed, the importance of enhancing the physiological relevance of <italic>in vitro</italic> systems and expanding their applications has increased exponentially to replace animal experiments as well as many other applications. Therefore, intensified efforts have been made toward systematic development and evaluation of relevant, reliable and more robust non-animal models.</p>
<p>The first attempts in alternative testing are based on the three Rs (3R principles, i.e., replacement, reduction, and refinement) (<xref ref-type="bibr" rid="B45">Russell and Burch, 1960</xref>). The 3Rs philosophy promotes the quest for 1) the replacement of animals with non-living models, 2) the reduction in the use of animals, and 3) the refinement of animal use practices. In this context, the Organization for Economic Cooperation and Development (OECD) allowed <italic>in vitro</italic> procedure that may be used for the hazard identification of irritant chemicals. It is based on reconstructed human epidermis (RhE), which in its overall design closely mimics the histological, morphological, biochemical, and physiological properties of the upper parts of the human skin (<xref ref-type="bibr" rid="B40">Organisation for Economic Co-operation and Development, 2020</xref>); (<xref ref-type="bibr" rid="B39">Organisation for Economic Co-operation and Development, 2015</xref>). This alternative approach has been thoroughly evaluated, validated and approved as a successful alternative for animal experimentation.</p>
<p>The three-dimensional (3D) <italic>in vitro</italic> models are an advanced approach to develop a full-thickness skin models that shows significant potential to evidently advance the engineering of skin replacements. Indeed, two examples of verified 3D models that are offered for sale commercially are the EpiDerm (<xref ref-type="bibr" rid="B30">MATTEK, 2020</xref>) skin model and the EPISKIN (<xref ref-type="bibr" rid="B24">LOREAL, 2020</xref>). Thus far, plenty of materials have been studied for their application in skin tissue engineering. Among these materials, a widely employed biomaterial in this field is gelatin, a protein obtained by partially hydrolyzing collagen, the main protein found in the skin, bones and white connective tissues of animals (<xref ref-type="bibr" rid="B15">Imeson, 1992</xref>). Besides the fact that gelatin has therapeutic properties for drug research or drug delivery, it also plays an important role in tissue engineering. Specifically, since it has the ability to create 3D porous structures in which cells can grow, this biomaterial can imitate <italic>in vivo</italic> microenvironment conditions. In fact, gelatin has been used to culture different cancer and stromal cells (<xref ref-type="bibr" rid="B36">Nii, 2021</xref>), (<xref ref-type="bibr" rid="B11">Ertekin et al., 2022</xref>), (<xref ref-type="bibr" rid="B35">Nii et al., 2020</xref>).</p>
<p>Currently, gelatin-hydrogel is used to support skin regeneration (<xref ref-type="bibr" rid="B53">Yehkung et al., 2011</xref>); (<xref ref-type="bibr" rid="B34">Nicodemus and Bryant, 2008</xref>); (<xref ref-type="bibr" rid="B13">Hoffman, 2012</xref>). <xref ref-type="bibr" rid="B54">Zhao et al. (2016)</xref> and co-workers revealed that the mechanical and degradation properties of a developed gelatin hydrogel can be modified by changing the hydrogel concentration. Furthermore, all concentrations of hydrogel showed excellent cell viability (&#x3e;90%) with increases in cell adhesion and proliferation that is proportional to the gelatin hydrogel concentration (<xref ref-type="bibr" rid="B55">Zhao et al., 2015</xref>). Additionally, the hydrogel is found to support keratinocytes growth, differentiation, and stratification into a reconstructed multilayered epidermis with adequate barrier functions (<xref ref-type="bibr" rid="B54">Zhao et al., 2016</xref>). The properties of this hydrogel suggest that the keratinocytes/fibroblasts filled hydrogels can be used as epidermal substitutes, wound dressings, or substrates to construct various <italic>in vitro</italic> skin models. Epidermal keratinocytes and dermal fibroblasts that interact together can actively participate in cutaneous immune responses and are two of the major cell types that respond to the inflammatory phase in the cutaneous repair/regeneration process. Despite the promising results, it is still hard to mimic the human body conditions and properties and the gelatin-hydrogel suffers from poor mechanical properties and high degradation rate that maybe not suitable for 3D <italic>in vitro</italic> keratinocytes and fibroblasts culture and new 3D <italic>in vitro</italic> models need to be validated. To improve mechanical features of our gelatin hydrogels, we used genipin as a natural crosslinker. Genipin is a molecule extracted from the fruit of the gardenia plant that has been used to crosslink a variety of protein and polysaccharide matrices, including gelatin for drug-delivery applications (<xref ref-type="bibr" rid="B21">Liang et al., 2003</xref>); (<xref ref-type="bibr" rid="B50">Wei et al., 2007</xref>); (<xref ref-type="bibr" rid="B6">Dare et al., 2009</xref>); (<xref ref-type="bibr" rid="B18">Ko et al., 2009</xref>).</p>
<p>In short, gelatin may serve as an effective platform to support culture systems, which is a step towards the design of more accurate 3D <italic>in vitro</italic> skin models and it paves the way for investigating the performance of a wide range of chemical and pharmaceutical safety assessment in the future on in vivo-like and animal-free approaches. Hence, this study aims to characterize the physical-chemical parameters for gelatin hydrogel crosslinked with genipin and to evaluate the biocompatibility of the engineering 3D keratinocytes and fibroblasts culture seeded on bioscaffold prior to the formation of a matured bilayer co-culture for future application <italic>in vitro</italic> 3D skin model.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Fabrication of gelatin hydrogel crosslinked with genipin</title>
<p>Gelatin hydrogel was fabricated from Nitta gelatin powder (Nitta Gelatin Inc<sup>&#xae;</sup>, Japan). The gelatin was mixed with distilled water with a magnetic stirrer until homogenized at 250&#xa0;rpm at 40&#xb0;C for 30&#xa0;min to remove air bubbles and to completely blend after adding the genipin (FUJIFILM Wako Pure Chemical Corporation<sup>&#xae;</sup>, Japan). Then, 2&#xa0;mL of the gelatin mixture was added to each well of a 12-well plate. The mixture was incubated at room temperature to initiate gelation to form the 3D constructs, which were termed gelatin10%-genipin0.1% (CL_GEL10%), gelatin8%-genipin0.1% (CL_GEL8%), gelatin5%-genipin0.1% (CL_GEL5%) and gelatin3%-genipin0.1% (CL_GEL3%) (<italic>n</italic> &#x3d; 3, N &#x3d; 3). Gelatin non crosslinked was used as control (NC_GEL10%), (NC_GEL8%), (NC_GEL5%), and (NC_GEL3%).</p>
<p>The gross morphology and microstructure of CL_GEL5% and CL_GEL8% constructs were observed via scanning electron microscopy (SEM; Quanta FEG 450, FEI; Eindhoven, North Brabant, Netherlands). The SEM analysis was performed to show the characteristics of the surface and porosity of different groups.</p>
</sec>
<sec id="s2-2">
<title>2.2 Physical and chemical characterization</title>
<sec id="s2-2-1">
<title>2.2.1 Porosity of gelatin hydrogel</title>
<p>The percentage of porosity of the gelatin hydrogel was measured by the below formula (<xref ref-type="bibr" rid="B46">School of Chemical Engineering, 2019</xref>). The measuring cylinder with the ethanol was recorded as V. The initial weight of the lyophilized gelatin hydrogel was recorded as <italic>Wd</italic>. The final weight of the immersed gelatin hydrogel in the 99.5% ethanol after 24&#xa0;h was recorded as <italic>Ws</italic>.<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>y</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>W</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>W</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>&#x3c1;</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">x</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>V</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mi>X</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Where <italic>&#x3c1;</italic> &#x3d; density of absolute ethanol.</p>
</sec>
<sec id="s2-2-2">
<title>2.2.2 Swelling ratio</title>
<p>The formula below was used to calculate how much volume of water the gelatin hydrogel can absorb. The bio-scaffold was weighed in a dry condition (<italic>Wd</italic>). After dry weight, the bio-scaffold was immersed into the phosphate buffer saline (PBS 1X, pH 7.4) for 6&#xa0;h. The wet bio-scaffold (<italic>Ws</italic>) was weighed and recorded at a constant time period (<xref ref-type="bibr" rid="B28">Maji et al., 2016</xref>).<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">w</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">S</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>W</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>W</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>W</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mi>X</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-2-3">
<title>2.2.3 Biodegradation</title>
<p>To observe the degradation of the gelatin hydrogel, the gelatin hydrogel was weighed first (<italic>W</italic>
<sub>0</sub>) after pre-freezing at &#x2212;80&#xb0;C for 6&#xa0;h and freeze-drying. The gelatin hydrogel was immersed in the diluted enzyme 0.0006% collagenase type I (Worthington<sup>&#xae;</sup>, NJ, United States) prepared in phosphate buffer saline (PBS 1X) and recorded in three different times 2, 4, and 24&#xa0;h (t), which imitated the human body&#x2019;s enzyme. After that, the gelatin hydrogel was washed using distilled water and pre-freeze at &#x2212;80&#xb0;C. The gelatin hydrogel underwent the freeze-drying process and its final weight was measured (<italic>W</italic>
<sub>t</sub>). The biodegradation rate and the weight loss were calculated by using the following formulas:<disp-formula id="equ3">
<mml:math id="m3">
<mml:mrow>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo>/</mml:mo>
<mml:mi mathvariant="normal">h</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi>W</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>W</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ4">
<mml:math id="m4">
<mml:mrow>
<mml:mi mathvariant="normal">W</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi>W</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>W</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mi>W</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-2-4">
<title>2.2.4 Degree of crosslinking</title>
<p>The ninhydrin assay (Sigma-Aldrich<sup>&#xae;</sup>, Saint Louis, MO, United States) was used to determine the degree of crosslinking of the sample. 10&#xa0;mg of the sample and 200&#xa0;&#xb5;L of ninhydrin reagent were added into a clean test tube. After the vortex, the sample which was covered by the aluminum foil was boiled for 2&#xa0;min. The sample was cooled before 200&#xa0;&#xb5;L of 95% ethanol was added into the test tube. We used the spectrophotometer reader (Bio-Tek<sup>&#xae;</sup>, Power Wave XS, Boston, United States) at 570&#xa0;nm to measure the absorbance of the sample and we compared the control sample without crosslinking and the sample with crosslinking by using the ninhydrin assay.</p>
</sec>
<sec id="s2-2-5">
<title>2.2.5 Contact angle</title>
<p>The gelatin hydrogel solutions were put on the glass slide and dried overnight. A water droplet was dropped on the glass slide in order to measure the angle of the gelatin hydrogel in contact with the surface of the glass slide by using ImageJ software (National Institute of Health, V1.5, Bethesda, MA, United States) to determine the surface wettability.</p>
</sec>
<sec id="s2-2-6">
<title>2.2.6 Compression and resilience</title>
<p>The formulas below were used to calculate the compression ratio and the resilience ratio. The gelatin hydrogel was compressed using a tensile testing analyzer (Instron, Norwood, MA, United States) and then released in water for 5&#xa0;min to observe the resilience. The hydrogel was compressed and released 3 times which needed to take a picture for every time.<disp-formula id="equ5">
<mml:math id="m5">
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">p</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">x</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ6">
<mml:math id="m6">
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">f</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">x</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>Where, A<sub>i</sub>: Area of thickness before compression. A<sub>c</sub>: Area of thickness after compression; A<sub>f</sub>: Area of thickness after resilience.</p>
</sec>
<sec id="s2-2-7">
<title>2.2.7 Fourier transform infrared spectrometry</title>
<p>The chemical structure of the constructs was characterized using Fourier transform infrared spectrometry (FTIR) (IR Prestige-21, Shimadzu<sup>&#xae;</sup>, Kyoto, Japan) through functional group identification. The CL_GEL5% and CL_GEL8% constructs were prepared as described above, and the FTIR spectra of the constructs (<italic>n</italic> &#x3d; 1) was recorded in the frequency range of 600&#x2013;4,000&#xa0;cm<sup>&#x2212;1</sup>. The data were analyzed using Shimadzu IR Solution FTIR (spectroscopy) software (Shimadzu<sup>&#xae;</sup>).</p>
</sec>
<sec id="s2-2-8">
<title>2.2.8 X-ray diffraction</title>
<p>The crystallographic structure analysis of the CL_GEL5% and CL_GEL8% biomaterials was performed by X-ray diffractometer (Bruker<sup>&#xae;</sup>, D8 Advance, United Kingdom) with diffraction angle (2&#x3b8;) in the range of 0<sup>&#x25e6;</sup> to 80<sup>&#x25e6;</sup>. The obtained diffractogram was evaluated by using the integrated software (Diffrac. Suite EVA, V4.0, Bruker<sup>&#xae;</sup>, Coventry, United Kingdom).</p>
</sec>
</sec>
<sec id="s2-3">
<title>2.3 Biocompatibility characterization</title>
<sec id="s2-3-1">
<title>2.3.1 Cell isolation and culture (keratinocytes and fibroblasts)</title>
<p>The six patients underwent abdominal surgery. The redundant skin samples were collected at Hospital Canselor Tuanku Mukhriz (HCTM) (Ethics approval number: UKM 1.5.3.5/244/FF-2015-376). The sample collection based on the inclusion and exclusion criteria listed in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Inclusive and exclusive criteria.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Inclusive criteria</th>
<th align="left">Exclusive criteria</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">&#x2022; The patient needs to do the abdominal surgery</td>
<td rowspan="3" align="left">&#x2022; Severe infections and/or ongoing antibiotic treatment</td>
</tr>
<tr>
<td align="left">&#x2022; Age is between 11 and 60&#xa0;years old</td>
</tr>
<tr>
<td align="left">&#x2022; The patient does not suffer from any chronic diseases</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>After collecting the redundant skin samples from patients who underwent abdominal surgery, the unwanted materials such as hair, fat, and debris were cleaned from the 3&#xa0;cm<sup>2</sup> of skin samples. The samples were cut into a few small pieces with approximately 2&#xa0;mm<sup>2</sup>. The cut pieces were incubated with 0.6% of collagenase type 1 (Worthington<sup>&#xae;</sup>, NJ, United States) in the 37&#xb0;C for digestion for 2&#x2013;4&#xa0;h. The cells were dissociated or degraded by using 0.05% of Trypsin-EDTA (Gibco<sup>&#xae;</sup>, CA, United States) for 8&#x2013;10&#xa0;min. The human epidermal keratinocytes (HEKs) and human dermal fibroblasts (HDFs) contained in the digested skin were resuspended in the co-culture medium at a 1:1 ratio (a mixture of HEKs growth medium; Epilife<sup>&#xae;</sup> (Gibco<sup>&#xae;</sup>, NY, United States) and HDF growth medium; F-12:Dulbecco&#x2019;s Modified Eagle Medium (Gibco<sup>&#xae;</sup>, United States) supplemented with 10% fetal bovine serum (FBS; Biowest<sup>&#xae;</sup>, MO, United States) (FDC). In the six-well culture plate, we seeded the medium in three wells that the surface area is 9.6&#xa0;cm<sup>2</sup>/well at 37&#xb0;C in 5% CO<sub>2</sub>. By using the differential trypsinization, the fibroblasts were separated from the co-cultured keratinocytes after the waste medium reached 70%&#x2013;80% confluence. The detached fibroblasts were re-cultured with FDC in a T75 flask. The keratinocytes were propagated in a six-well culture plate and the desired number of cells was obtained by the sub-culture fibroblasts and keratinocytes for further analysis. Three technical replicates were performed for each biological replicate.</p>
</sec>
<sec id="s2-3-2">
<title>2.3.2 Cell attachment</title>
<p>HDFs (5 &#xd7; 10<sup>4</sup>) and HEKs (15 &#xd7; 10<sup>4</sup>) were seeded on hydrogels of different formulations, which were presoaked in F12: DMEM (Gibco<sup>&#xae;</sup>, NY, United States) and Epilife<sup>&#xae;</sup> (Gibco<sup>&#xae;</sup>, NY, United States) with supplements, respectively, overnight. The cells were allowed to attach at 37&#xb0;C with 5% CO<sub>2</sub>. The hydrogel was washed gently with Dulbecco&#x2019;s Phosphate Buffer Saline (DPBS) (Sigma<sup>&#xae;</sup>, MO, United States) after 24&#xa0;h. The remaining (unattached) cells in DPBS were counted using a hemocytometer and 0.4% trypan blue solution (Sigma<sup>&#xae;</sup>, MO, United States). The percentage of cell attachment was calculated as per the equation below:</p>
<p>Cell attachment (%) &#x3d; [(Initial cell seeding &#x2212; number of cells in DPBS)/Initial cell seeding] x 100.</p>
</sec>
<sec id="s2-3-3">
<title>2.3.3 Cell toxicity assessment</title>
<p>Cytotoxicity test was performed towards HEKs and HDFs via LIVE/DEAD cytotoxicity assay for mammalian cells (Thermo Fisher Scientific<sup>&#xae;</sup>, MA, United States). The hydrogels were fabricated in a 48-well culture plate by using sterile gelatin and genipin solution. Immediately after polymerization, 5 &#xd7; 10<sup>4</sup> HDFs and 15 &#xd7; 10<sup>4</sup> HEKs at passage three (P3) were seeded on the top of hydrogel prior to the incubation for 24&#xa0;h. Cell toxicity was examined by using a fluorescence microscope (Nikon<sup>&#xae;</sup> A1R-A1, Japan) at &#xd7;10 magnification after treatment with 500&#xa0;&#xb5;L of a mixture of 2&#xa0;mM acetomethoxy derivative of calcein (calcein-AM) and 4&#xa0;mM ethidium homodimer-1 (EthD-1) at 37&#xb0;C for 30&#xa0;min.</p>
</sec>
<sec id="s2-3-4">
<title>2.3.4 Viability and proliferation evaluation</title>
<p>The viability and proliferation of HEKs and HDFs were evaluated by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Thermo Fisher Scientific<sup>&#xae;</sup>, MA, United States). Briefly, 5 &#xd7; 10<sup>4</sup> HDFs and 15&#xd7; 10<sup>4</sup> HEKs at P3 (<xref ref-type="bibr" rid="B37">Nike et al., 2021</xref>); (<xref ref-type="bibr" rid="B51">Xi Loh et al., 2018</xref>) were seeded on the top of hydrogel according to the protocol previously described elsewhere (<xref ref-type="bibr" rid="B29">Masri et al., 2023</xref>); (<xref ref-type="bibr" rid="B31">Mh Busra et al., 2019</xref>) and MTT reagent was added after 1, 3, 5 and 7&#xa0;days of incubation prior to the dimethyl sulfoxide (DMSO) addition as dissolution reagent. The absorbance was recorded by using a spectrophotometer reader (Bio-Tek<sup>&#xae;</sup>, Power Wave XS, Washington, United States) at 540&#xa0;nm at specific time intervals. The cellular viability at day 1 was used as an indicator of the efficiency of HDFs and HEKs attachment. The total number of cells was calculated using the standard curve.</p>
</sec>
<sec id="s2-3-5">
<title>2.3.5 Cell migration</title>
<p>The migration ability of the HDFs and HEKs in 3D hydrogels was evaluated by using gelatin-hydrogel models in which cells were seeded. The net migration of the cell population was measured from an upper chamber to a lower chamber through a microporous membrane. Subsequently, a 1&#xa0;cm<sup>2</sup> of each hydrogel was used for cell seeding in 48 well-plates. The cells were stained with blue cell tracker (Hoescht dye, Invitrogen<sup>&#xae;</sup>, MA, United States) and green cell tracker (Green dye, Invitrogen<sup>&#xae;</sup>, MA, United States) and incubated for 30&#xa0;min in 37&#xb0;C. HDFs and HEKs were stabilized for 2 and 24&#xa0;h, respectively. Next, 5 &#xd7; 10<sup>4</sup> HDFs and 15&#xd7; 10<sup>4</sup> HEKs stained with green dye were seeded on the top of the scaffolds of each group and 5 &#xd7; 10<sup>4</sup> HDFs and 15&#xd7; 10<sup>4</sup> HEKs stained with blue dye were seeded in 48-well plate. The fluorescent dye retained in the cells allowing for multigenerational tracking of cellular movements. Meanwhile, the gelatin-cells constructs were monitored at day 1, 3, 5 and 7 to observe the cell migration from the transplanted site to the surrounding matrix. Cell migration images were captured using Nikon A1R confocal microscope (Nikon<sup>&#xae;</sup>, Japan), and cell migration distances from the hole edge to the cell outgoing front in all directions were measured via image analysis software (ImageJ) (National Institute of Health, V1.5, MA, United States). Afterward, the average migration distance was calculated for statistical analysis.</p>
</sec>
<sec id="s2-3-6">
<title>2.3.6 Immunocytochemistry staining for proliferative cells</title>
<p>Keratinocytes and fibroblasts were fixed with 4% paraformaldehyde (Sigma-Aldrich<sup>&#xae;</sup>, MO, United States) for at least 15&#xa0;min, permeabilized with 0.1% Triton X-100 solution (Sigma-Aldrich<sup>&#xae;</sup>, MO, United States) for 20&#xa0;min, and blocked with 10% goat serum (Sigma-Aldrich<sup>&#xae;</sup>, MO, United States) for 1&#xa0;h at 37&#xb0;C. Next, the cells were incubated with mouse collagen type 1 monoclonal antibody (COL-I) (Abcam<sup>&#xae;</sup>, United Kingdom), rabbit alpha-smooth muscle actin antibody (&#x3b1;-SMA) (Abcam<sup>&#xae;</sup>, United Kingdom) and rabbit cytokeratin 14 antibody (CK-14) (Abcam<sup>&#xae;</sup>, United Kingdom) overnight at 4&#xb0;C. On the next day, the cells were incubated with goat anti-mouse IgG Alexa Fluor 594 (Red-fluorescent dye, Invitrogen<sup>&#xae;</sup>, MO, United States) and goat anti-rabbit IgG Alexa Fluor 488 (Green-fluorescent dye, Invitrogen<sup>&#xae;</sup>, MO, United States) for 2&#xa0;h at 37&#xb0;C in dark. The cells then were counterstained with DAPI (Dako<sup>&#xae;</sup>, Denmark) for 20&#xa0;min at room temperature and observed using Nikon A1R confocal microscope (Nikon<sup>&#xae;</sup>, Japan) for expression of collagen type 1, &#x3b1;-SMA and cytokeratin 14.</p>
</sec>
</sec>
<sec id="s2-4">
<title>2.4 Develop a two-layer skin construct</title>
<sec id="s2-4-1">
<title>2.4.1 Preparation of the two-layer skin construct</title>
<p>The ability of the fibroblasts and keratinocytes to migrate into a gelatin hydrogel was compared in four-time intervals (on days 1, 3, 5 and 7 after cell seeding) and the CL_GEL5% and the CL_GEL8% gelatin hydrogels were selected for the preparation of the two-layer skin construct. Thus, a two-layer cell construct was composed of a CL_GEL5% and CL_GEL8% gelatin hydrogel pre-seeded with HDFs. A 1.9&#xa0;cm<sup>2</sup> of gelatin hydrogel samples were fitting into 12-well cell culture plates and seeded with HDFs. The fibroblasts were seeded on the scaffold at a density of 50,000 cells, (<xref ref-type="bibr" rid="B37">Nike et al., 2021</xref>); (<xref ref-type="bibr" rid="B31">Mh Busra et al., 2019</xref>) and were cultivated in FD supplemented with 10% of FBS and 1% of antibacterial-antimycotic (Gibco<sup>&#xae;</sup>, China). After 3&#xa0;days of fibroblast cultivation, the collagen hydrogel was prepared on the fibroblast-seeded membrane, and the fibroblasts started to migrate into the hydrogel. The keratinocytes were seeded at a density of 150,000 cells after 4&#xa0;days of gelatin hydrogel preparation (already seeded with of fibroblasts). After the keratinocytes had been seeded, the medium was replaced by FD and Epilife with supplements, as mentioned above. The medium was changed every 2&#xa0;days. After 7, 14 and 21&#xa0;days of fibroblast cultivation, the immunohistochemistry (IHC) and hematoxylin and eosin staining (H&#x26;E) were performed in order to evaluate the reepithelization of the skin constructs.</p>
</sec>
<sec id="s2-4-2">
<title>2.4.2 Hydrogel frozen section technique</title>
<p>The frozen section method is a rapid and efficient technique for soft tissue analysis. Using a cryostat, the portion of hydrogels (1&#xa0;cm diameter) were immediately frozen. The freezing procedure normally takes a few minutes and preserves the original condition of the tissue. Next, using a microtome, the hydrogels were sliced into thin sections with 4&#xa0;&#x3bc;m thickness. Sectioned hydrogels were subjected for hematoxylin and eosin (H&#x26;E) and immunofluorescent (IF) staining to make them visible under microscope.</p>
</sec>
<sec id="s2-4-3">
<title>2.4.3 Hematoxylin and eosin staining</title>
<p>The H&#x26;E staining was used to detect the nucleus and extracellular matrix (ECM) protein, allowing the identification of structural features of the epidermis and dermis layer. The H&#x26;E staining was carried out according to standard protocol. The hydrogel samples were first fixed in a solution such as 10% formalin, to preserve the hydrogels. First, the hydrogel samples were embedded in optimal cutting temperature (OCT) compound and snap-frozen in liquid nitrogen or dry ice. The frozen tissue block was then sectioned using a cryostat to a thickness of 4&#xa0;&#x3bc;m and left for air dried. The hydrogel-sectioned slides were then dipped in H&#x26;E solution for 5&#x2013;10&#xa0;min. Next, the slides were then rinsed in distilled water and immersed in eosin solution for 30&#xa0;s. Following that, the slides were rinsed with distilled water again before being dehydrated with graded alcohol solutions (70%, 90%, and 100% ethanol). Lastly, the slides were cleaned using xylene, and mounted with a coverslip using a mounting medium and ready to be observed under light microscope.</p>
</sec>
<sec id="s2-4-4">
<title>2.4.4 Immunofluorescent staining</title>
<p>IHC was carried out using specific markers, cytokeratin 14 and collagen type 1 (Abcam<sup>&#xae;</sup>, MA, United States) to evaluate, respectively, the regenerated skin&#x2019;s maturity for keratinocytes and the fibroblasts maturity. The hydrogels were then sectioned with a cryostat and mounted on glass slides. The fixed tissue sections were then blocked with 10% goat serum (Sigma Aldrich<sup>&#xae;</sup>, MO, United States) to prevent non-specific binding of the primary antibody. The tissue sections were incubated with a primary antibody that specifically binds to the protein of interest. The tissue sections are then incubated with a secondary antibody that recognizes the primary antibody Alexa 488 (Abcam<sup>&#xae;</sup>, MA, United States). The labelled secondary antibody is detected using fluorescence microscopy. Finally, the tissue sections counterstained with DAPI to visualize the nuclei and provide morphological context.</p>
</sec>
</sec>
<sec id="s2-5">
<title>2.5 Statistical analysis</title>
<p>The quantitative results were shown as mean &#xb1; standard error mean (SEM). Statistical analyses were performed using GraphPad Prism 7.0 (GraphPad Software, United States) and the results were analyzed using one-way analysis of variance (ANOVA). The difference between groups is significant if <italic>p</italic> &#x3c; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Characterization of hydrogels</title>
<sec id="s3-1-1">
<title>3.1.1 Gross appearance</title>
<p>The gelatin hydrogel scaffolds were fabricated with four different concentrations of gelatin crosslinked or non-crosslinked with genipin, respectively (CL_Gel 10%&#x2014;CL_GEL 8% - CL_GEL 5% and CL_GEL 3%) and (NC_Gel 10% - NC_GEL 8% - NC_GEL 5% and NC_GEL 3%). <xref ref-type="fig" rid="F1">Figure 1A</xref> shows the gross appearance of gelatin hydrogel with or without crosslinking. The scaffold crosslinked with genipin showed a greenish blue color as compared to the non-crosslinked one. In contrast, the non-crosslinked hydrogel showed a transparent structure. The crosslinked hydrogel was semi-solid gel and showed a smooth surface. The structure of the gel appeared to be more solid in the scaffolds with the highest concentration of gelatin. The same observation was observed in the non-crosslinked groups. Despite using the same material, these scaffolds vary in their gross appearance.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> Gross appearance of different gelatin hydrogel groups (3%,5%,8%, and 10%) non-crosslinked and crosslinked with 0.1% genipin at room temperature (22&#xb0;&#x2013;24&#xb0;C). The crosslinked groups with 0.1% genipin showed greenish blue color while the non-crosslinked groups showed transparent structure. <bold>(B)</bold> Physical evaluation: swelling ratio of gelatin hydrogel scaffolds, i.e., GEL3%, GEL5%, GEL 8%, and GEL10% with and without genipin crosslinking. The non-crosslinked groups demonstrated higher swelling properties compared to crosslinked groups. &#x2a;Represents the significant difference between crosslinked and non-crosslinked hydrogel (N &#x3d; 3, <italic>n</italic> &#x3d; 3).</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g001.tif"/>
</fig>
</sec>
<sec id="s3-1-2">
<title>3.1.2 Swelling ratio</title>
<p>The swelling ratio was determined as shown in <xref ref-type="fig" rid="F1">Figure 1B</xref>. The NC_GEL 3% hydrogel scaffold demonstrated the best swelling property (2268.63 &#xb1; 136.9%) compared to the other experimental groups followed by the NC_GEL 5% (1556.05 &#xb1; 120.98%) and the CL_GEL 3% (1079.52 &#xb1; 38.42%). Meanwhile, the NC_GEL 10% hydrogel had the poorest swelling property (633.22 &#xb1; 27.4%), followed by CL_GEL 10% (698.52 &#xb1; 24.88%) and NC_GEL 8% (844.40 &#xb1; 70.52%). As the ratio of the polymers in the hydrogel was changed, keeping the crosslinker constant, swelling is increased. It was also found that the sample was unstable in the aqueous solution and was challenging to handle. It can be easily observed by the large error bars especially in the non-crosslinked groups.</p>
<p>One of the desired properties that plays a crucial role in cell adhesion and development as well as transfer of nutrients and metabolites via the hydrogel (<xref ref-type="bibr" rid="B44">Rodr&#xed;guez-V&#xe1;zquez et al., 2015</xref>), is water permeability. It was reported that the ability of the bioscaffold to absorb fluid 80 times over its initial weight is adequate for skin tissue engineering (<xref ref-type="bibr" rid="B25">Luangbudnark et al., 2012</xref>). The hydrogel concentration in our study caused a growing proportion of swelling in all constructions where the ability of CL_GEL8% to swell was almost 100 times over its initial weight, which is consistent with the gelatin&#x2019;s microporous structure and porosity.</p>
</sec>
<sec id="s3-1-3">
<title>3.1.3 <italic>In vitro</italic> biodegradation</title>
<p>Given that cells seeded in a hydrogel may secrete several proteases, such as collagenase, which could lead to hydrogel degradation, the degradation performance of gelatin hydrogel was evaluated. The degradation test was carried out in all groups. The biodegradation rates of the scaffolds were evaluated using the enzymatic degradation approach, as shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>. The non-crosslinked scaffolds (NC_GEL10%, NC_GEL8%, NC_GEL5%, and NC_GEL3%) together, were able to degrade faster (59.59 &#xb1; 1.45&#xa0;mg/h) than crosslinked gelatin hydrogels (CL_GEL10%, CL_GEL8%, CL_GEL5%, and CL_GEL3%) together (2.58 &#xb1; 0.47&#xa0;mg/h). The addition of genipin was able to decrease the degradation rate in the scaffolds dramatically. The weight loss test was carried out in all groups as shown in <xref ref-type="fig" rid="F2">Figure 2B</xref>. After 2&#xa0;h, the weight loss of the non-crosslinked groups was (69.85% &#xb1; 3.68%), and (83.97% &#xb1; 2.3%) in NC_GEL10% and NC_GEL8%, respectively and after 24&#xa0;h, the weight loss of the non-crosslinked groups was 100%. After 2&#xa0;h, the highest weight loss percentage in crosslinked group was in CL_GEL3% (8.87% &#xb1; 0.53%) and the lowest value was in CL_GEL8% (3.72% &#xb1; 0.17%). After 4&#xa0;h, the CL_GEL3% registered the highest value of weight loss (10.94% &#xb1; 0.38%) and CL_GEL8% (7.61% &#xb1; 0.29%) registered the lowest value. And after 24&#xa0;h, the CL_GEL5% showed the highest value (55.15% &#xb1; 3.41%) followed by CL_GEL3% (31.27% &#xb1; 1.96%) and CL_GEL8% (23.62% &#xb1; 1.52%) and CL_GEL10% (10.49% &#xb1; 2.39%). It seems that, the gelatin hydrogel concentration significantly helps in decreasing the weight loss. Comparing the crosslinked groups, the increase of gelatin hydrogel concentration helps in slowing down the weight loss process in crosslinked formulation.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Biodegradation rate and <bold>(B)</bold> weight loss at 37&#xb0;C of the fabricated scaffolds compared to control at various times (2, 4, and 24&#xa0;h). <bold>(C)</bold> Water contact angle of the fabricated scaffolds at room temperature. <bold>(D)</bold> compression and <bold>(E)</bold> resilience properties of the different hydrogel formulations compared to control. <bold>(F)</bold> Degree of crosslinking of the fabricated scaffolds. <bold>(G)</bold> measurement of water contact angle with ImageJ software &#x2a; Represents the significant difference between groups.</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g002.tif"/>
</fig>
<p>Another way to improve the mechanical properties of the hydrogels is by using biodegradable synthetic scaffolds. The biodegradable hydrogel would serve as a substrate for the initial attachment and growth of fibroblasts and keratinocytes (<xref ref-type="bibr" rid="B26">MacNeil, 2007</xref>). Our results showed that the gelatin hydrogel concentration was found to significantly help in decreasing the weight loss, which indicates the possibility to control the degradation rate by changing the hydrogel formulation as reported by <xref ref-type="bibr" rid="B54">Zhao et al. (2016)</xref> and coworkers. Also, the addition of GNP as a crosslinker was able to decrease dramatically the degradation rate in the scaffolds. The same results were reported by <xref ref-type="bibr" rid="B31">Mh Busra et al. (2019)</xref>; Ke et al.; <xref ref-type="bibr" rid="B41">Ren et al. (2017)</xref>. For skin tissue engineering, it follows that the scaffold degradation rate coincides with the generation rate of new skin (<xref ref-type="bibr" rid="B33">Nam et al., 2012</xref>); (<xref ref-type="bibr" rid="B4">Branco da Cunha et al., 2014</xref>).</p>
</sec>
<sec id="s3-1-4">
<title>3.1.4 Contact angle</title>
<p>The water contact angle (<xref ref-type="fig" rid="F2">Figure 2G</xref>) is important for determining hydrogel hydrophilicity or hydrophobicity, an essential factor in drug delivery, cell proliferation and adherence. The contact angle results of all groups are shown in <xref ref-type="fig" rid="F2">Figure 2C</xref>. The contact angle revealed a range from (12.1&#xb0; &#xb1; 1.2&#xb0;) to (9.5&#xb0; &#xb1; 0.9&#xb0;). No significance association was found among the groups. This shows that our scaffolds have very hydrophilic properties.</p>
</sec>
<sec id="s3-1-5">
<title>3.1.5 Compression and resilience</title>
<p>The compression and resilience results of all groups are shown in <xref ref-type="fig" rid="F2">Figures 2D, E</xref>, respectively. The NC_GEL5% showed the highest value in compression, without a significant difference, compared to other groups with (37.5% &#xb1; 4.7%). The lowest value was recorded in CL_GEL10% (7.03% &#xb1; 0.2%) followed by CL_GEL5%, and CL_GEL8% with (9.1% &#xb1; 1.7%) and (12.6% &#xb1; 1.3%), respectively. The NC_GEL10% recorded the highest resilience value with (167.3% &#xb1; 8.9%) followed by CL_GEL3% (143.7% &#xb1; 3.5%) and CL_GEL5% (135.9% &#xb1; 1.4%). The lowest resilience value was in CL_GEL8% (101.4% &#xb1; 0.2%) followed by NC_GEL8% (113% &#xb1; 0.6%). All groups represent a high resilience value superior than 100%.</p>
<p>The appropriate mechanical stability and the ability of the scaffolds to resemble the skin stiffness are crucial to select the appropriate biomaterial (<xref ref-type="bibr" rid="B33">Nam et al., 2012</xref>), (<xref ref-type="bibr" rid="B52">Xie et al., 2017</xref>). In the current study, the compression tests showed compression values between 7% and 37% in CL_GEL5%, CL_GEL8%, and CL_GEL10%, which suggest that gelatin concentration plays a crucial role in improving mechanical strength. It has been reported that fibroblasts show thick stress fibers when cultured on rigid substrate compared to soft scaffolds where the stress fibers are less thick or even absent (<xref ref-type="bibr" rid="B33">Nam et al., 2012</xref>), (<xref ref-type="bibr" rid="B52">Xie et al., 2017</xref>). All groups had resilience rates more than 100. High resilience shows optimum hydrogel elasticity, which is desired for shape recovery during application to maintain its efficacity (<xref ref-type="bibr" rid="B22">Liu et al., 2016</xref>). Resilience and adhesive force properties could be improved with GNP crosslinking by creating an intermolecular bridge between gelatin molecules through the covalent bond (<xref ref-type="bibr" rid="B17">Kirchmajer et al., 2013</xref>), (<xref ref-type="bibr" rid="B2">Arif et al., 2020</xref>). The crucial contribution of gelatin hydrogels towards strengthening mechanical properties has also been demonstrated in previous studies (<xref ref-type="bibr" rid="B43">Rodr&#xed;guez-Rodr&#xed;guez et al., 2019</xref>), (<xref ref-type="bibr" rid="B2">Arif et al., 2020</xref>).</p>
</sec>
<sec id="s3-1-6">
<title>3.1.6 Degree of crosslinking</title>
<p>The degree of crosslinking results of all groups are shown in <xref ref-type="fig" rid="F2">Figure 2F</xref>. The results show that the CL_GEL3% has the highest degree of crosslinking followed by the CL_GEL8% with (52.49% &#xb1; 8.8%) and (52.02% &#xb1; 2.5%), respectively. The poorest degree of crosslinking was recorded in the CL_GEL10% followed by CL_GEL5% with (26.76% &#xb1; 2.7%) and (30.72% &#xb1; 3.4%), respectively.</p>
</sec>
<sec id="s3-1-7">
<title>3.1.7 Porosity and scanning electron microscope</title>
<p>The porosity, which is the percentage of void volume in a material, was determined as shown in <xref ref-type="fig" rid="F3">Figure 3A</xref>. The CL_GEL 3% hydrogel scaffold demonstrated the highest porosity property (66.88% &#xb1; 5.76%) compared to the other experimental groups followed by the NC_GEL 3% (53.81% &#xb1; 2.03%) and NC_GEL 5% (50.68% &#xb1; 3.18%). Meanwhile, the CL_GEL 10% (18.87% &#xb1; 2.22%) had the poorest porosity property, followed by the CL_GEL 8% (27.84% &#xb1; 5.54%).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<bold>(A)</bold>: Physical evaluation: porosity of gelatin hydrogel scaffolds non-crosslinked and crosslinked, i.e., GEL3%, GEL5%, GEL 8%, and GEL10%. Overall, the non-crosslinked groups demonstrated higher porosity properties compared to crosslinked groups. <bold>(B)</bold> View under scanning electron microscope of <bold>(B)</bold> CL_Gel5% at magnification of &#xd7;100, scale 100&#xa0;&#xb5;m (B1); magnification of &#xd7;200, scale 100&#xa0;&#xb5;m (B2&#x2013;B4); and magnification of 1.00&#xa0;K X, scale 10&#xa0;&#xb5;m (B5-B6). <bold>(C)</bold> View under scanning electron microscope of CL_Gel8% at magnification of &#xd7;100, scale 100&#xa0;&#xb5;m (C1-C2); magnification of &#xd7;200, scale 100&#xa0;&#xb5;m (C3); magnification of 1.00&#xa0;KX, scale 20&#xa0;&#xb5;m (C4) and); magnification of 1.00KX, scale 10&#xa0;&#xb5;m (C5-C6).</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g003.tif"/>
</fig>
<p>The results of the scanning electron microscope (SEM) of CL_GEL5% and CL_GEL8% are shown in <xref ref-type="fig" rid="F3">Figures 3B, C</xref>, respectively. SEM analysis showed that the CL_GEL 5% scaffold had interconnected pores with size range of 40&#x2013;183&#xa0;&#x3bc;m. The SEM analysis showed that the CL_GEL8% scaffold had interconnected pores with size range of 39&#x2013;170&#xa0;&#x3bc;m.</p>
<p>The biomaterial properties of the scaffolds are vital in determining the cells behavior and the full reepithelization of the tissue. Therefore, the 3D scaffolds should be highly porous with interconnected pores to enable the diffusion of oxygen, nutrient and the waste removal (<xref ref-type="bibr" rid="B23">Loh and Choong, 2013</xref>). According to earlier research, porous materials with a range within 20&#x2013;125&#xa0;&#xb5;m are optimum to reconstruct adult skin (<xref ref-type="bibr" rid="B48">Sisso et al., 2020</xref>); (<xref ref-type="bibr" rid="B42">Rodr&#xed;guez-Rodr&#xed;guez et al., 2020</xref>); (<xref ref-type="bibr" rid="B10">El-Sherbiny and Yacoub, 2013</xref>) and pore sizes within 40&#x2013;600&#xa0;&#xb5;m promote capillary ingrowth (<xref ref-type="bibr" rid="B5">Crowley et al., 2016</xref>); (<xref ref-type="bibr" rid="B7">de Mel et al., 2009</xref>). The SEM results of the CL_GEL5% and the CL_GEL8% show that the range of the pore sizes is within 40&#x2013;183&#xa0;&#x3bc;m and 39&#x2013;170&#xa0;&#x3bc;m; respectively, which is acceptable for tissue regeneration. However, The porosity of all four hydrogel formulations was between 18% and 60% this is fell short of several other biomaterials studied in the literature, which might approach 80%&#x2013;90% porosity (<xref ref-type="bibr" rid="B49">Wang et al., 2016</xref>), (<xref ref-type="bibr" rid="B27">Mahboudi et al., 2015</xref>). The porosity and pore size determine the ultimate mechanical quality of the scaffold, which affects cell behavior (<xref ref-type="bibr" rid="B27">Mahboudi et al., 2015</xref>).</p>
</sec>
<sec id="s3-1-8">
<title>3.1.8 Energy dispersive X-Ray (EDX) composition analysis</title>
<p>The results of the energy dispersive X-Ray composition analysis of CL_GEL5% and CL_GEL8% groups are shown in <xref ref-type="sec" rid="s11">Supplementary Figure S1A</xref>. Elemental study of CL_GEL5% and CL_GEL8% treatment groups revealed three main components, including nitrogen (N; 11%), carbon (C; 60%&#x2013;80%), and oxygen (O; 25%&#x2013;30%) in CL_GEL5%, and (C; 55%&#x2013;60%), (N; 25%),(O; 10%&#x2013;25%) in CL_GEL8%, as shown in <xref ref-type="sec" rid="s11">Supplementary Figures S1A1, A2</xref>, respectively.</p>
</sec>
<sec id="s3-1-9">
<title>3.1.9 Fourier transform infrared spectrometry</title>
<p>The Fourier transform infrared spectrometry (FTIR) results of CL_GEL5% and CL_GEL8% are presented in <xref ref-type="sec" rid="s11">Supplementary Figures S1B1, B2</xref>, respectively. The FTIR revealed 4 regions, the region A, B, C and D. The IR spectra of CL_GEL8% and CL_GEL5% showed similar absorbances resembling the Amide A (3,400&#x2013;2,300&#xa0;cm<sup>&#x2212;1</sup>), Amide I (1,600&#x2013;1,650&#xa0;cm<sup>&#x2212;1</sup>), Amide II (1,530&#x2013;1,200&#xa0;cm<sup>&#x2212;1</sup>), and Amide III (1,230&#x2013;670&#xa0;cm<sup>&#x2212;1</sup>). No major shift was prominent in FTIR spectra in both formulations after genipin modification as described in a previous study (<xref ref-type="bibr" rid="B37">Nike et al., 2021</xref>). Briefly, at the A region, the amine group attack O-H group. CL-GEL8% had highest O-H group (3,285.94&#xa0;cm<sup>&#x2212;1</sup>) and lower crosslinking followed by CL_GEL5% (3,283.59&#xa0;cm<sup>&#x2212;1</sup>). The region B and C showed that CL_GEL5% had the highest Amide I (1,631&#xa0;cm<sup>&#x2212;1</sup>) and Amide II (1,544.78&#xa0;cm<sup>&#x2212;1</sup>) followed by CL_GEL8% (Amide I (1,629.55&#xa0;cm<sup>&#x2212;1)</sup>) (Amide II (1,541.58&#xa0;cm<sup>&#x2212;1</sup>). At region D, both CL_GEL5% and CL_GEL8% presented almost the same level of Amide III (1,238.32&#xa0;cm<sup>&#x2212;1</sup> and 1,238.72&#xa0;cm<sup>&#x2212;1</sup>), respectively<bold>.</bold>
</p>
</sec>
<sec id="s3-1-10">
<title>3.1.10 X-ray diffraction</title>
<p>The X-ray diffractogram of fabricated hydrogels demonstrated almost similar patterns for both CL_GEL5% and CL_GEL8% treatment groups as shown in <xref ref-type="sec" rid="s11">Supplementary Figures S1C1, C2</xref>, respectively. All diffractograms represented a broad peak at 2&#x3b8; in between 10&#xb0; to 50&#xb0;. The XRD patterns for CL_GEL5% described CL_GEL8% due to similar gelatin initial stock except for its concentration. CL_GEL5% presented the highest percentage of crystallinity with 29.3% and 70.7% of amorphous followed by CL_GEL8% with 15.5% of crystallinity and 84.5% of amorphous. As expected, the EDX, FTIR and the XRD analysis demonstrated that GNP did not affect the native chemical properties of gelatin.</p>
</sec>
</sec>
<sec id="s3-2">
<title>3.2 Biocompatibility characterization</title>
<sec id="s3-2-1">
<title>3.2.1 Cell isolation and culture (keratinocytes and fibroblasts)</title>
<p>The primary culture of human epidermal keratinocytes and human dermal fibroblast were successfully established from skin samples (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Monolayer cells cultured in 6-well plate: <bold>(A)</bold> culture of human epidermal keratinocytes (HEKs), and <bold>(B)</bold> human dermal fibroblasts (HDFs), The cultured cells became confluent in a week&#x2019;s time and fibroblasts were separated by differential trypsinization before seeding into a new flask. Scale bar: 100&#xa0;&#x3bc;m, magnification &#xd7;4.</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g004.tif"/>
</fig>
</sec>
<sec id="s3-2-2">
<title>3.2.2 Cell attachment</title>
<p>HDFs and HEKs were seeded on top of the gelatin hydrogel scaffolds (CL_GEL3%, CL_GEL5%, CL_GEL8%, and CL_GEL10%), and the efficiency of cell attachment was evaluated at 24&#xa0;h after seeding (<xref ref-type="fig" rid="F5">Figures 5A1, B1</xref>). All groups showed a high attachment property and the CL_GEL 10% (98.75% &#xb1; 0.38%) scaffolds demonstrated the highest attachment of HEKs compared to other scaffolds followed by the CL_GEL 8% (98.16% &#xb1; 0.72%), CL_GEL 5% (97% &#xb1; 0.57%) and CL_GEL 3% (93.83% &#xb1; 0.44%). The same observation goes with the HDFs where the CL_GEL 10% showed the highest attachment property with (94.33% &#xb1; 4.66%) followed by CL_GEL 8% (89.33% &#xb1; 1.7%), CL_GEL 5% (78% &#xb1; 4%) and CL_GEL 3% (76.33% &#xb1; 4.33%). The attachment properties of the gelatin hydrogel scaffolds increased proportionally with the concentration of gelatin. Additionally, the scaffolds with different formulations presented a higher attachment property for HEKs than HDFs.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Cell attachment (%) of <bold>(</bold>A1): human epidermal keratinocytes (HEKs) and (B1): human dermal fibroblasts (HDFs) in CL_GEL3%, CL_GEL5%, CL_GEL8%, and CL_GEL10% formulations after 24&#xa0;h. Cell migration (&#xb5;m) of (A2) keratinocytes and (B2) fibroblasts of CL_GEL3%, CL_GEL5%, CL_GEL8%, and CL_GEL10% at various interval times (day 3, 5 and 7). (A3) Three-dimensional (3D) confocal image of cell migration (&#xb5;m) on days 1, 3, 5 and 7 of CL_GEL5% and CL_GEL8% of keratinocytes (Green: cell tracker; Blue: Hoescht dye), the green color demonstrated that the cells are migrating from an upper chamber to a lower chamber through a microporous membrane. Live/dead staining of (A4) human epidermal keratinocytes (HEKs) and (B3) human dermal fibroblasts (HDFs) seeded on (1) CL_GEL10%, CL_GEL8%, CL_GEL5% and CL_GEL3%, after 24&#xa0;h. The results revealed non-cytotoxic effect of gelatin hydrogel crosslinked with genipin. The green color demonstrated live (HEKs) and (HDFs) cells. Scale bar &#x3d; 100&#xa0;&#xb5;m (10X). (Green: live cells; Red: dead cells).</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g005.tif"/>
</fig>
<p>Our fabricated 3D gelatin hydrogel showed favorable characteristics in terms of stability and in supporting the attachment of HDFs and HEKs as expected. The properties that may affect cell attachment like hydrophilicity, pore size, surface roughness, were almost similar between the different formulations and were favorable for cell attachment. This suggests that the gelatin hydrogel exhibits rapid cell attachment as more than 90% of HEKs and HDFs are already attached after 24&#xa0;h. The excellent attachment rate may be explained by the hydrophilicity of the hydrogel and the surface area reasonably available for the cells to attach as the porosity is rather low. This property is very important for cell function including cell spreading, migration and proliferation (<xref ref-type="bibr" rid="B1">Anselme et al., 2010</xref>).</p>
</sec>
<sec id="s3-2-3">
<title>3.2.3 Cell toxicity assessment</title>
<p>HEKs and HDFs were seeded on top of the gelatin hydrogel scaffolds, and the efficiency of cell attachment and viability were evaluated at 24&#xa0;h after seeding as shown in <xref ref-type="fig" rid="F5">Figures 5A4, B3</xref>, respectively. All groups showed a high attachment property and high viability. The CL_GEL 10% scaffolds demonstrated the higher attachment and viability of HDFs compared to other scaffolds. All scaffolds demonstrated a high attachment and viability of HEK.</p>
<p>The results for the cell viability assay demonstrated a high number of live cells and a very low number of dead cells on all formulations of hydrogel, this confirms that the hydrogel supports cell viability and provides nontoxic 3D scaffolds.</p>
</sec>
<sec id="s3-2-4">
<title>3.2.4 Cell migration</title>
<p>The cell migration results of HEKs and HDFs are shown in <xref ref-type="fig" rid="F5">Figures 5A2, B2</xref>, respectively. <xref ref-type="fig" rid="F4">Figure 5A3</xref> showed HEKs migrating from an upper chamber to a lower chamber (upper chamber cells stained in blue, migrated cells stained in green). HEKs and HDFs did migrate into the hydrogel as the cells did not and remained at the top surface on day 3, 5 and 7 unlike the first day where the cells seemed to be at the same level with the attached cells in the plate (upper chamber).</p>
<p>At the third day, the highest distance of migration in HEKs (&#xb5;m) was recorded in CL_GEL3% followed by CL_GEL8% with (119.8 &#xb1; 2.01&#xa0;&#xb5;m) and (96.23 &#xb1; 3.8&#xa0;&#xb5;m). The lowest distance of migration was recorded in CL_GEL10% with (55.2 &#xb1; 1.7&#xa0;&#xb5;m). For HDFs, the CL_GEL3% showed the highest distance of migration with (359.29 &#xb1; 2.5&#xa0;&#xb5;m) followed by CL_GEL10% with (76.8 &#xb1; 1.4&#xa0;&#xb5;m) and the lowest migration distance for HDFs was recorded in CL_GEL5% with (72.3 &#xb1; 1.5&#xa0;&#xb5;m), but no significant difference was observed between CL_GEL5% and CL_GEL8%. The results showed a significant difference between CL_GEL3% and all other groups at the third day.</p>
<p>At the fifth day, HEKs showed the highest distance of migration in the hydrogel CL_GEL3% followed by the CL_GEL5% with (149.96 &#xb1; 3.1&#xa0;&#xb5;m) and (142 &#xb1; 3.7&#xa0;&#xb5;m), respectively. The lowest distance was recorded also in CL_GEL10% with (84.22 &#xb1; 1.8&#xa0;&#xb5;m). The results showed a significant difference among all the groups except for CL_GEL3% and CL_GEL5%. HDFs showed the highest distance of migration in the hydrogel CL_GEL3% followed by the CL_GEL5% with (374.66 &#xb1; 1.9&#xa0;&#xb5;m) and (206.36 &#xb1; 1.2&#xa0;&#xb5;m), respectively. The lowest distance was recorded in CL_GEL8% and CL_GEL10% with (79.02 &#xb1; 1.2&#xa0;&#xb5;m) and (80.58 &#xb1; 1.5&#xa0;&#xb5;m), respectively with no significant difference. The results show a significant difference among the other groups.</p>
<p>At the seventh day, the HEKs migrated the longest distance in CL_GEL5% followed by CL_GEL3% with (160.01 &#xb1; 3.9&#xa0;&#xb5;m) and (158.56 &#xb1; 2&#xa0;&#xb5;m), respectively with no significant difference, while the shortest distance was reported in CL_GEL10% with (99.74 &#xb1; 1.5&#xa0;&#xb5;m). All others groups showed significant difference. HDFs showed the highest distance of migration in the hydrogel CL_GEL3% followed by the CL_GEL5% and the CL_GEL8% with (390.75 &#xb1; 3.5&#xa0;&#xb5;m), (303.36 &#xb1; 1.6&#xa0;&#xb5;m), and (184.8 &#xb1; 1.2&#xa0;&#xb5;m), respectively. The lowest distance was recorded in CL_GEL10% with (84.34 &#xb1; 2.2&#xa0;&#xb5;m). The results showed significant difference among all groups.</p>
<p>Cell migration within scaffolds is crucial for skin tissue adaptation. The results of cell migration on different formulations were significantly different among groups. The CL_GEL3%, CL_GEL5%, and CL_GEL8%, showed positive results in cell migration after 7&#xa0;days with a range of 390&#xa0;&#x3bc;m, 303&#xa0;&#x3bc;m and 184&#xa0;&#xb5;m in HDF and 158&#xa0;&#x3bc;m, 160&#xa0;&#x3bc;m, and 136&#xa0;&#xb5;m in HEK; respectively. It has been reported that the optimum pore size for fibroblasts is between 20 and 120&#xa0;&#xb5;m which goes along with our results in CL_GEL5% and CL_GEL8%. This suggests that the pore sizes within 39&#x2013;170 and the pore size within 40&#x2013;183&#xa0;&#xb5;m are suitable for HEKs and HDFs migration on gelatin hydrogel. The scaffolds should promote HEKs and HDFs adhesion and migration and allow the retention of metabolic functions of attached cells. However, The CL_GEL10% did not allowed the migration of HDFs and HEKs which may be due to the small pore sizes caused by the increasing of the gelatin concentration. This indicates that the CL_GEL10% is not suitable for cell migration. <xref ref-type="bibr" rid="B38">Oliveira Barud et al. (2015)</xref>, reported that even with an average pore size of 102 &#xb1; 5.43, no noticeable migration of fibroblasts was observed on bacterial cellulose/50% fibroin scaffold and they suggest that this is due to the dense network that do not generate enough pore size to facilitate cell migration. We suggest also that the CL_GEL10% did not promote the HEKs and the HDFs, perhaps, because of the dense network created by gelatin-genipin hydrogel that does not possess enough pores with the suitable size for the cell migration compared to all other formulations. It is noteworthy that the HDFs migrate better than HEKs which could be due to their capacity to adapt.</p>
</sec>
<sec id="s3-2-5">
<title>3.2.5 Immunocytochemistry</title>
<p>HDF on both CL_GEL5% and CL_GEL8% revealed the positive expression of &#x3b1;-SMA (green); and collagen type 1 (red) as shown in <xref ref-type="fig" rid="F6">Figures 6A2, A3</xref>, respectively. However, the number of &#x3b1;-SMA and collagen type 1 positive cells was low compared to that of total cells. In addition, if we compare the cell behavior on the hydrogel and on the 2-dimentional (2-D) cell culture control (<xref ref-type="fig" rid="F6">Figure 6A1</xref>), the number of the adherent cells was significantly higher in the control in both groups. On the other hand, HEK on both scaffolds showed the presence of cytokeratin 14 (green) and the number of cytokeratin 14 positive cells was high (<xref ref-type="fig" rid="F6">Figures 6B2, B3</xref>). Interestingly, the number of the adherent cells in the CL_GEL5% and the CL_GEL8% was higher than the 2D control (<xref ref-type="fig" rid="F6">Figure 6B1</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Immunocytochemistry staining of collagen type 1, &#x3b1;-SMA, and cytokeratin 14. <bold>(A)</bold> Immunocytochemistry staining of human dermal fibroblasts (HDFs) on (A1) monolayer 2D culture as control; (A2) CL_GEL5% and (A3) CL_GEL8%. The cells were stained with immunofluorescence (Alexa 594, red; COL I), (Alexa 488, green; &#x3b1;-SMA) and with Hoechst (blue; cell nuclei). HDFs on both CL_GEL5% and CL_GEL8% demonstrated the presence of &#x3b1;-SMA (green) positive cells; and collagen type 1 (red) positive cells. <bold>(B)</bold> Immunocytochemistry staining of human epidermal keratinocytes (HEKs) on (B1) monolayer 2D culture as control; (B2) CL_GEL5% and (B3) CL_GEL8%. The cells were stained by immunofluorescence (Alexa 488, green; CK-14) and with Hoechst (blue; cell nuclei). HEKs on both CL_GEL5% and CL_GEL8% demonstrated the presence of cytokeratin 14 (green) positive cells. Scale bar: 100&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g006.tif"/>
</fig>
<p>In order to investigate the maturation process, the changes in the expression of cytokeratin 14 in HEKs and the expression of &#x3b1;-SMA and collagen type 1 in HDFs were examined. The cytokeratin 14, a type 1 keratin, is mainly located in the basal keratinocytes of the epidermis, stratified epithelia and in the hair follicle&#x2019;s exterior root sheet (<xref ref-type="bibr" rid="B47">Seet et al., 2012</xref>). The positive results suggest that CL_GEL5% and CL_GEL8% promote the differentiation of keratinocytes and fibroblasts. The increased expression of this marker of basal keratinocytes proliferating in the CL_GEL5% and CL_GEL8% groups compared to the 2-D control indicated more layers of proliferating keratinocytes, which suggests that HEKs were in an earlier phase of maturation. On the other hand, collagen type 1 was highly expressed in 2-D fibroblasts culture, which suggests that there was no disruption of collagen type 1 level. However, collagen type 1 was scarcely present in the CL_GEL5% and CL_GEL8% groups, which suggests that the HDFs are still in the earlier phase of maturation compared to 2-D controls. The results showed that there was more collagen type 1 in the control compared to the hydrogel groups loaded with cells which does not match the cell viability and cell attachment findings. It is known that during the remodeling and maturation phase of wound healing, collagen type III is remodeled to collagen type 1 (<xref ref-type="bibr" rid="B32">Miedel et al., 2015</xref>), which supports the finding that the treatment using hydrogel loaded with cells promote regeneration faster than using the hydrogel alone. However, this our results contradict this observation as the hydrogel does not promote the HDFs maturation.</p>
<p>In addition, The expression of &#x3b1;-SMA is linked to myofibroblasts, which are involved in tissue contraction (<xref ref-type="bibr" rid="B8">Desmouliere et al., 2014</xref>). In physiological remodeling, the contractile activity of myofibroblasts is terminated when the tissue is repaired; &#x3b1;-SMA expression subsequently decreases and myofibroblasts are removed by apoptosis (<xref ref-type="bibr" rid="B9">Desmouli&#xe8;re et al., 1995</xref>). In our experiments, the expression of &#x3b1;-SMA in the 2D control group was the highest, which suggests that differentiation is much faster compared to the gelatin hydrogel groups.</p>
</sec>
<sec id="s3-2-6">
<title>3.2.6 Cell proliferation</title>
<p>MTT assay confirmed that HDFs and HEKs proliferations were too low compared to the 2D culture control as shown in <xref ref-type="fig" rid="F7">Figures 7A, B</xref>, respectively. At the third day, the CL_GEL5% showed the highest cell viability in HDFs followed by CL_GEL8% with 68.033 &#xb1; 5.3 and 53.03 &#xb1; 4.9; respectively compared to 164.77 &#xb1; 11.5 in 2D HDFs control. This rate decreased to 42.86 &#xb1; 3.55 and 40.84 &#xb1; 3 in CL_GEL5% and CL_GEL8%; respectively after 7&#xa0;days. However, the cell viability in control increased to 282.88 &#xb1; 21.8. The cell viability in HEKs was lower compared to HDFs. At the third day, the highest cell viability was recorded in CL_GEL3% followed by CL_GEL5% and CL_GEL8% with 31.31 &#xb1; 1.5, 23.95 &#xb1; 1.1 and 22.6 &#xb1; 0.7; respectively. The cell viability was higher in 2D HEKs control with 110.4 &#xb1; 11.4. After 7&#xa0;days, the cells proliferate slightly in CL_GEL3% with 41.67 &#xb1; 4.3, in CL_GEL8% with 25.5 &#xb1; 2.03 and in CL_GEL5% with 24.77 &#xb1; 0.45 which is lower compared to the 2D HEKs control (71.05 &#xb1; 7.9). All groups showed low viability and proliferation of HDFs and HEKs compared to 2D controls.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Cell proliferation of <bold>(A)</bold> human dermal fibroblasts (HDFs) and <bold>(B)</bold> human epidermal keratinocytes (HEKs) seeded on gelatin hydrogel 3D scaffolds (CL_GEL3%, CL_GEL5%, CL_GEL8%, and CL_GEL10%) and 2D controls after 1,3,5 and 7&#xa0;days. HDFs and HEKs proliferations were too low compared to the 2D culture controls. &#x2a;Control group significantly higher compared to other groups for both cell types.</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g007.tif"/>
</fig>
<p>Cellular compatibility is another concern for an ideal bioscaffold for skin tissue engineering to maintain viability and support human skin cells proliferation. Unfortunately, all gelatin hydrogel groups showed a negative proliferative effect on HDFs and HEKs as the proliferation was either too low or decreasing which is not consistent with previous findings from <xref ref-type="bibr" rid="B14">Ilkar Erdagi et al. (2020)</xref>. Unfortunately, the proliferation of HDF at the top surface of hydrogels was decreased after 7&#xa0;days incubation and the proliferation of HEKs was slightly increased but still very low compared to the control. This phenomenon is probably related to its mechanical strength, as was reported previously by <xref ref-type="bibr" rid="B20">Lee et al. (2014)</xref> who concluded that a limited proliferative effect occurred in the hydrogel with higher stiffness due to slower degradation and lower permeability (<xref ref-type="bibr" rid="B12">Gupta et al., 2019</xref>).</p>
</sec>
<sec id="s3-2-7">
<title>3.2.7 Histological and immunohistochemical analysis of skin maturation</title>
<p>The H&#x26;E staining was carried out to verify the maturity level of the 3D <italic>in vitro</italic> skin model using hydrogels. For comparison, we used both HEKs and HDFs cells to construct <italic>in vitro</italic> skin models using hydrogels. <xref ref-type="fig" rid="F8">Figure 8A</xref> displays the H&#x26;E-stained images of the hydrogels under different incubation periods (7, 14, and 21&#xa0;days). From day 7 until day 21 incubation, the presence of stratified keratinocytes that are exposed to air was indicated in both CL_GEL 5%, and CL_GEL 8%. It can be seen from the images that about two layers occurred which indicates the separation of epidermis and dermis layer. Nonetheless, due to an insufficient incubation period, both formulations were unable to attain sufficient maturity to form a suprabasal layer or thicken the spinous layer. In addition, there is no presence of fibroblasts cells in the inner layer of the hydrogels.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Microscopic evaluation of hydrogel model <bold>(A)</bold> H&#x26;E-stained images of hydrogels performed on day 7, 14, and 21 (scale bar: 200&#xa0;&#x3bc;m), <bold>(B)</bold> immunofluorescent images of hydrogels to detect the presence of collagen type 1 on day 7, 14, and 21 (&#xd7;20 magnification), <bold>(C)</bold> immunofluorescent images of hydrogels to detect the presence of cytokeratin 14 on day 7, 14, and 21 (&#xd7;20 magnification).</p>
</caption>
<graphic xlink:href="fbioe-11-1200618-g008.tif"/>
</fig>
</sec>
<sec id="s3-2-8">
<title>3.2.8 Immunofluorescent analysis of skin maturation</title>
<p>The skin model was constructed by cultivating mixed skin cells (HEKs and HDFs) onto gelatin hydrogels. Thus, we examined the expression marker of collagen type 1, and cytokeratin 14 using immunofluorescent staining. <xref ref-type="fig" rid="F8">Figure 8B</xref> showed the immunofluorescent stained images of the hydrogels using collagen type 1 marker for day 7, 14, and 21. Results showed that collagen type 1 staining was present in both CL_GEL 5% and CL_GEL 8% microstructure Day 7 only. This indicates that there is no HDFs in both CL_GEL 5% and CL_GEL 8% on day 14 and 21 incubation period. Moreover, <xref ref-type="fig" rid="F8">Figure 8C</xref> shows the IF-stained images of hydrogels using cytokeratin 14 marker for day 7, 14, and 21. Cytokeratin 14 is known as an important marker for epidermal basal cell detection. The results indicate that CL_GEL 5% and CL_GEL 8% expressed higher level of cytokeratin 14 on day 7 while CL_GEL 8% slightly expressed cytokeratin 14 on day 14. This indicates that the 3D <italic>in vitro</italic> models are not fully matured after 21&#xa0;days of incubation.</p>
<p>Complex biofabricated scaffolds cannot be employed immediately after fabrication as <italic>in vitro</italic> tissue models. The generation of a fully functional skin equivalent that closely resembles the structure and functionality of native skin is required for the maturation of a hydrogel-based 3D <italic>in vitro</italic> skin model. This includes the successfully differentiation of keratinocytes to form epidermis layers, and the development of dermal compartment with fibroblasts and extracellular matrix.</p>
<p>Generally, tissue maturation requires ideal circumstances, including culture environment, time, and medium composition (nutrition) to support cell growth. Based on our findings, the presence of separation layers between epidermis and dermis. This phenomenon have been occurred and explained by <xref ref-type="bibr" rid="B19">Kwak et al. (2018)</xref> who mentioned that the epidermis&#x2019; differentiation was triggered by air exposure. Moreover, our histological findings also found that the 3D <italic>in vitro</italic> model using CL_GEL 5%, and CL_GEL 8% were not fully matured after 21&#xa0;days incubation period. Longer cultured of HEKs and HDFs in the hydrogels did not increase the expression of collagen type 1 and cytokeratin 14. This finding was similar with a previous study by <xref ref-type="bibr" rid="B16">Kim et al. (2019)</xref> who developed a 3D <italic>in vitro</italic> model using hydrogels claimed that it is not sufficient to prove that their skin model recapitulates a more accurate and predictive <italic>in vivo</italic> response given in the milieu of original skin.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Our three-dimensional (3D) scaffolds demonstrated good physical and chemical properties (hydrophilic, crosslinked polymeric networks, high swelling rate, biodegradation) while maintaining their 3D structure except for Gel3% that was excluded. All gelatin hydrogel groups were compatible for skin tissue engineering applications in cellular attachment, cell viability but not for cell proliferation. Considering that the intended use of the hydrogel is to serve as a skin substitute, the ability to maintain cell attachment and viability is not sufficient for its function as cell proliferation deemed important to ensure a full regeneration of the HDFs and HEKs. Insufficient incubation time and the absence of additional measures to enhance cell differentiation could represent limitations in our study. We require a longer period of incubation and additional adjustments to further stimulate cell differentiation and regeneration. Future studies could focus on modifying the hydrogel composition to enhance its ability to promote cell proliferation and further investigate the potential of these 3D scaffolds for skin tissue engineering applications. We also suggest exploring the use of different cell concentrations and increasing the initial number of cells to address the limitations of skin maturation in our model.</p>
<p>The 3D <italic>in vitro</italic> skin model made from gelatin hydrogel has several applications, including as an alternative to animal experiments in preclinical studies, for screening for toxicity of various substances, for studying wound healing and disease modeling, and for developing personalized medicine. Overall, this model has the potential to provide a more accurate and reliable testing platform, accelerate the development of new treatments for skin-related conditions, and reduce the need for animal testing.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Research Ethic Committee Universiti Kebangsaan Malaysia (UKM), Malaysia. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>Conception and design: MF and MM. Analysis and interpretation of the data: ST, MF, MM, and SM. Drafting of the article: ST. Critical revision of the article for important intellectual content: MF, MM, and HM. Final approval of the article: MF, MM, and HM. Provision of study materials or patients: MF, MM, and RC. Statistical expertise: ST. Obtaining of funding: MF and MM. Collection and assembly of data: ST and SM. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>Geran Fundamental Fakulti Perubatan (GFFP), Faculty of Medicine, Universiti Kebangsaan Malaysia, Grant code: FF-2021-491 for research fund. No funding for open access publication under this grant.</p>
</sec>
<ack>
<p>The authors would like to acknowledge financial support from UKM Medical Centre (Fundamental Grant Code: FF-2021-491).</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflicts of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2023.1200618/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2023.1200618/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S1</label>
<caption>
<p>Chemical characterization. <bold>(A)</bold> Energy dispersive X-Ray (EDX) map and spectra gave information that the presence of the element in the surface of (A1) CL_GEL5% and (A2) CL_GEL8% were similar to NC_GEL5% and NC_GEL8% (data not shown). <bold>(B)</bold> Fourier Transform Infrared Spectrometry (FTIR) spectra of (B1) CL_GEL5% and (b2) CL_GEL8%. <bold>(C)</bold> X-ray diffractogram of (C1) CL_GEL5% and (C2) CL_GEL8% confirmed that genipin modification did not alter the origin functional groups and amorphous nature of gelatin.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image1.JPEG" id="SM1" mimetype="application/JPEG" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anselme</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ploux</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ponche</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Cell/material interfaces: Influence of surface chemistry and surface topography on cell adhesion</article-title>. <source>J. Adhes. Sci. Technol. janv</source> <volume>24</volume> (<issue>5</issue>), <fpage>831</fpage>&#x2013;<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1163/016942409x12598231568186</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arif</surname>
<given-names>M. M. A.</given-names>
</name>
<name>
<surname>Fauzi</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Nordin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hiraoka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yunus</surname>
<given-names>M. H. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Fabrication of bio-based gelatin sponge for potential use as A functional acellular skin substitute</article-title>. <source>Polymers</source> <volume>12</volume> (<issue>11</issue>), <fpage>2678</fpage>. <pub-id pub-id-type="doi">10.3390/polym12112678</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gulotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Junker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Drasler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lehner</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Understanding the development, standardization, and validation process of alternative <italic>in vitro</italic> test methods for regulatory approval from a researcher perspective</article-title>. <source>Small. avr</source> <volume>17</volume> (<issue>15</issue>), <fpage>2006027</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202006027</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Branco da Cunha</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Klumpers</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Koshy</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Influence of the stiffness of three-dimensional alginate/collagen-I interpenetrating networks on fibroblast biology</article-title>. <source>Biomaterials</source> <volume>35</volume> (<issue>32</issue>), <fpage>8927</fpage>&#x2013;<lpage>8936</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.06.047</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crowley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Klanrit</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Varanou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Plat&#xe9;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hynds</surname>
<given-names>R. E.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold</article-title>. <source>Biomater. mars</source> <volume>83</volume>, <fpage>283</fpage>&#x2013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.01.005</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dare</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Poitras</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kaupp</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Genipin cross-linked fibrin hydrogels for <italic>in vitro</italic> human articular cartilage tissue-engineered regeneration</article-title>. <source>Cells Tissues Organs</source> <volume>190</volume> (<issue>6</issue>), <fpage>313</fpage>&#x2013;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1159/000209230</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Mel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Punshon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ramesh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Darbyshire</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>
<italic>In situ</italic> endothelialisation potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft</article-title>. <source>Biomed. Mater Eng.</source> <volume>19</volume> (<issue>4-5</issue>), <fpage>317</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.3233/bme-2009-0597</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desmouliere</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Laverdet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bont&#xe9;</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Fibroblasts and myofibroblasts in wound healing</article-title>. <source>Clin. Cosmet. Investig. Dermatol. Nov.</source> <volume>7</volume>, <fpage>301</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.2147/ccid.s50046</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desmouli&#xe8;re</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Redard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Darby</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gabbiani</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar</article-title>. <source>Am. J. Pathol. janv</source> <volume>146</volume> (<issue>1</issue>), <fpage>56</fpage>&#x2013;<lpage>66</lpage>.</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sherbiny</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Yacoub</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Hydrogel scaffolds for tissue engineering: Progress and challenges</article-title>. <source>Glob. Cardiol. Sci. Pract. Sept.</source> <volume>2013</volume> (<issue>3</issue>), <fpage>38</fpage>. <pub-id pub-id-type="doi">10.5339/gcsp.2013.38</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ertekin</surname>
<given-names>&#xd6;.</given-names>
</name>
<name>
<surname>Monavari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fuentes-Chand&#xed;a</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Letort</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>3D hydrogel-based microcapsules as an <italic>in vitro</italic> model to study tumorigenicity, cell migration and drug resistance</article-title>. <source>Acta Biomater. avr</source> <volume>142</volume>, <fpage>208</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2022.02.010</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kowalczuk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heaselgrave</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Britland</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Radecka</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The production and application of hydrogels for wound management: A review</article-title>. <source>Eur. Polym. J. f&#xe9;vr</source> <volume>111</volume>, <fpage>134</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2018.12.019</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Hydrogels for biomedical applications</article-title>. <source>Adv. Drug Deliv. Rev. d&#xe9;c</source> <volume>64</volume>, <fpage>18</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.09.010</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilkar Erdagi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Asabuwa Ngwabebhoh</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yildiz</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Genipin crosslinked gelatin-diosgenin-nanocellulose hydrogels for potential wound dressing and healing applications</article-title>. <source>Int. J. Biol. Macromol. avr</source> <volume>149</volume>, <fpage>651</fpage>&#x2013;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.01.279</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Imeson</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1992</year>). <source>Thickening and gelling agents for food</source>. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>Springer US</publisher-name>.</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>3D cell printing of perfusable vascularized human skin equivalent composed of epidermis, dermis, and hypodermis for better structural recapitulation of native skin</article-title>. <source>Adv. Healthc. Mater</source> <volume>8</volume> (<issue>7</issue>), <fpage>1801019</fpage>&#x2013;<lpage>1801111</lpage>. <pub-id pub-id-type="doi">10.1002/adhm.201801019</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirchmajer</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Ranson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Panhuis</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Gelapin, a degradable genipin cross-linked gelatin hydrogel</article-title>. <source>RSC Adv.</source> <volume>3</volume> (<issue>4</issue>), <fpage>1073</fpage>&#x2013;<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1039/c2ra22859a</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>I. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering</article-title>. <source>J. Biosci. Bioeng. f&#xe9;vr</source> <volume>107</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiosc.2008.09.020</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwak</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>won</surname>
<given-names>Jeon J.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>
<italic>In vitro</italic> 3D skin model using gelatin methacrylate hydrogel</article-title>. <source>J. Ind. Eng. Chem.</source> <volume>66</volume>, <fpage>254</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiec.2018.05.037</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K. D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Enzyme-catalyzed <italic>in situ</italic> forming gelatin hydrogels as bioactive wound dressings: Effects of fibroblast delivery on wound healing efficacy</article-title>. <source>J. Mater Chem. B</source> <volume>2</volume> (<issue>44</issue>), <fpage>7712</fpage>&#x2013;<lpage>7718</lpage>. <pub-id pub-id-type="doi">10.1039/c4tb01111b</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>H. W.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration:<italic>in vitro</italic> and<italic>in vivo</italic> studies</article-title>. <source>J. Biomed. Mater Res. 1 mai</source> <volume>65A</volume> (<issue>2</issue>), <fpage>271</fpage>&#x2013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.10476</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Darabi</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Highly flexible and resilient elastin hybrid cryogels with shape memory, injectability, conductivity, and magnetic responsive properties</article-title>. <source>Adv. Mater. Sept.</source> <volume>28</volume> (<issue>35</issue>), <fpage>7758</fpage>&#x2013;<lpage>7767</lpage>. <pub-id pub-id-type="doi">10.1002/adma.201601066</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loh</surname>
<given-names>Q. L.</given-names>
</name>
<name>
<surname>Choong</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size</article-title>. <source>Tissue Eng. Part B Rev. d&#xe9;c</source> <volume>19</volume> (<issue>6</issue>), <fpage>485</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2012.0437</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="web">
<collab>LOREAL</collab> (<year>2020</year>). <article-title>Celebrating pride month with L&#x27;or&#xe9;al</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="www.loreal.com">www.loreal.com</ext-link> (accessed November, 2020)</comment>.</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luangbudnark</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Viyoch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Laupattarakasem</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Surakunprapha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Laupattarakasem</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Properties and biocompatibility of chitosan and silk fibroin blend films for application in skin tissue engineering</article-title>. <source>Sci. World J.</source> <volume>2012</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1100/2012/697201</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacNeil</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Progress and opportunities for tissue-engineered skin</article-title>. <source>Nat. f&#xe9;vr</source> <volume>445</volume> (<issue>7130</issue>), <fpage>874</fpage>&#x2013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1038/nature05664</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahboudi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pezeshki-Modaress</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Noghabi</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The study of fibroblast cell growth on the porous scaffold of gelatin&#x2013;starch blend using the salt-leaching and lyophilization method</article-title>. <source>Int. J. Polym. Mater Polym. Biomater.</source> <volume>64</volume> (<issue>12</issue>), <fpage>653</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1080/00914037.2014.1002095</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maji</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pramanik</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bissoyi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Preparation and evaluation of gelatin-chitosan-nanobioglass 3D porous scaffold for bone tissue engineering</article-title>. <source>Int. J. Biomater.</source> <volume>2016</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1155/2016/9825659</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maarof</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Idrus</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fauzi</surname>
<given-names>M. B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Performance of hybrid gelatin-PVA bioinks integrated with genipin through extrusionbased 3D bioprinting: An <italic>in vitro</italic> evaluation using human dermal fibroblasts</article-title>. <source>Int. J. Bioprinting</source> <volume>9</volume> (<issue>3</issue>), <fpage>677</fpage>. <comment>Disponible sur: Available at:</comment>. <pub-id pub-id-type="doi">10.18063/ijb.677</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="web">
<collab>MATTEK</collab> (<year>2020</year>). <article-title>Supporting your science</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="www.mattek.com">www.mattek.com</ext-link> (accessed November, 2020)</comment>.</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mh Busra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rajab</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Saim</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Idrus R</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rapid treatment of full&#x2010;thickness skin loss using ovine tendon collagen type I scaffold with skin cells</article-title>. <source>J. Tissue Eng. Regen. Med. mai</source> <volume>13</volume> (<issue>5</issue>), <fpage>874</fpage>&#x2013;<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1002/term.2842</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miedel</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Brisson</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gleason</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Lopas</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Type III collagen modulates fracture callus bone formation and early remodeling: col3 modulates fracture repair</article-title>. <source>J. Orthop. Res. mai</source> <volume>33</volume> (<issue>5</issue>), <fpage>675</fpage>&#x2013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1002/jor.22838</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kishida</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Fabrication of a heterostructural fibrillated collagen matrix for the regeneration of soft tissue function</article-title>. <source>Soft Matter</source> <volume>8</volume> (<issue>2</issue>), <fpage>472</fpage>&#x2013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1039/c1sm06543b</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicodemus</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Cell encapsulation in biodegradable hydrogels for tissue engineering applications</article-title>. <source>juin</source> <volume>14</volume> (<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2007.0332</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nii</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Three-dimensional culture system of cancer cells combined with biomaterials for drug screening</article-title>. <source>Cancers</source> <volume>12</volume> (<issue>10</issue>), <fpage>2754</fpage>. <pub-id pub-id-type="doi">10.3390/cancers12102754</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nii</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Strategies using gelatin microparticles for regenerative therapy and drug screening applications</article-title>. <source>Molecules</source> <volume>26</volume> (<issue>22</issue>), <fpage>6795</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26226795</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nike</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Katas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mohd</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hiraoka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Idrus</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Characterisation of rapid <italic>in situ</italic> forming gelipin hydrogel for future use in irregular deep cutaneous wound healing</article-title>. <source>Polymers</source> <volume>13</volume> (<issue>18</issue>), <fpage>3152</fpage>. <pub-id pub-id-type="doi">10.3390/polym13183152</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira Barud</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Barud</surname>
<given-names>H. da S.</given-names>
</name>
<name>
<surname>Cavicchioli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>do Amaral</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Junior Ob de</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Preparation and characterization of a bacterial cellulose/silk fibroin sponge scaffold for tissue regeneration</article-title>. <source>Carbohydr. Polym. Sept.</source> <volume>128</volume>, <fpage>41</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2015.04.007</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="book">
<collab>Organisation for Economic Co-operation and Development</collab> (<year>2015</year>). <source>Vitro skin irritation: Reconstructed human epidermis test method, OECD guidelines for the testing of chemicals, section 4 test No. 439</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD Publishing</publisher-name>.</citation>
</ref>
<ref id="B40">
<citation citation-type="book">
<collab>Organisation for Economic Co-operation and Development</collab> (<year>2020</year>). <source>Vitro skin irritation: Reconstructed human epidermis test method, OECD guidelines for the testing of chemicals, section 4 test No. 439</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD Publishing</publisher-name>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Electrospun PCL/gelatin composite nanofiber structures for effective guided bone regeneration membranes</article-title>. <source>Mater Sci. Eng. C. Sept.</source> <volume>78</volume>, <fpage>324</fpage>&#x2013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2017.04.084</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Rodr&#xed;guez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Espinosa-Andrews</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Velasquillo-Mart&#xed;nez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Carvajal</surname>
<given-names>Z. Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Composite hydrogels based on gelatin, chitosan and polyvinyl alcohol to biomedical applications: A review</article-title>. <source>Int. J. Polym. Mater Polym. Biomater. 2 janv</source> <volume>69</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1080/00914037.2019.1581780</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Rodr&#xed;guez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Carvajal</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez-Palomar</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez-Avalos</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Espinosa-Andrews</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Development of gelatin/chitosan/PVA hydrogels: Thermal stability, water state, viscoelasticity, and cytotoxicity assays</article-title>. <source>J. Appl. Polym. Sci. 10 mars</source> <volume>136</volume> (<issue>10</issue>), <fpage>47149</fpage>. <pub-id pub-id-type="doi">10.1002/app.47149</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-V&#xe1;zquez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vega-Ruiz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ramos-Z&#xfa;&#xf1;iga</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Salda&#xf1;a-Koppel</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Qui&#xf1;ones-Olvera</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Chitosan and its potential use as a scaffold for tissue engineering in regenerative medicine</article-title>. <source>Biomed. Res. Int.</source> <volume>2015</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1155/2015/821279</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>W. M. S.</given-names>
</name>
<name>
<surname>Burch</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>1960</year>). <article-title>The principles of humane experimental technique</article-title>. <source>Med. J. Aust. mars</source> <volume>1</volume> (<issue>13</issue>), <fpage>500</fpage>.</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<collab>School of Chemical Engineering</collab> (<year>2019</year>). <article-title>Universiti Sains Malaysia, George Town, Malaysia, et al. M. Injectable collagen-chitosan hydrogel using ultrasonic pretreated ovine tendon collagen</article-title>. <source>Int. J. Adv. Appl. Sci. d&#xe9;c</source> <volume>3</volume>(<issue>12</issue>), <fpage>58</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.21833/ijaas.2019.12.006</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seet</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Maarof</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khairul Anuar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Ahmad Irfan</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>M. H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Shelf-life evaluation of bilayered human skin equivalent, MyDerm&#x2122;</article-title>. <source>MyDerm<sup>TM</sup>. Brand. JM, &#xc9;diteur. PLoS ONE. 23 ao&#xfb;t</source> <volume>7</volume> (<issue>8</issue>), <fpage>e40978</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0040978</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sisso</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Boit</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>DeForest</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Self&#x2010;healing injectable gelatin hydrogels for localized therapeutic cell delivery</article-title>. <source>J. Biomed. Mater Res. A. mai</source> <volume>108</volume> (<issue>5</issue>), <fpage>1112</fpage>&#x2013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.36886</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A biomimetic silk fibroin/sodium alginate composite scaffold for soft tissue engineering</article-title>. <source>Sci. Rep. d&#xe9;c</source> <volume>6</volume> (<issue>1</issue>), <fpage>39477</fpage>. <pub-id pub-id-type="doi">10.1038/srep39477</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W. W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>P. H.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium</article-title>. <source>J. Control. Release. juill</source> <volume>120</volume> (<issue>1-2</issue>), <fpage>27</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2007.04.005</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi Loh</surname>
<given-names>E. Y.</given-names>
</name>
<name>
<surname>Fauzi</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ariffin</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Cellular and molecular interaction of human dermal fibroblasts with bacterial nanocellulose composite hydrogel for tissue regeneration</article-title>. <source>ACS Appl. Mater Interfaces</source> <volume>10</volume> (<issue>46</issue>), <fpage>39532</fpage>&#x2013;<lpage>39543</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b16645</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bruekers</surname>
<given-names>S. M. C.</given-names>
</name>
<name>
<surname>Huck</surname>
<given-names>W. T. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Collagen gels with different fibrillar microarchitectures elicit different cellular responses</article-title>. <source>ACS Appl. Mater Interfaces. 14 juin</source> <volume>9</volume> (<issue>23</issue>), <fpage>19630</fpage>&#x2013;<lpage>19637</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b03883</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yehkung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y. ming</given-names>
</name>
<name>
<surname>Chengming</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>N. T.</given-names>
</name>
<name>
<surname>che</surname>
<given-names>Liu C.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>J. jong</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A novel cell support membrane for skin tissue engineering: Gelatin film cross-linked with 2-chloro-1-methylpyridinium iodide</article-title>. <source>Polym. f&#xe9;vr</source> <volume>52</volume> (<issue>4</issue>), <fpage>996</fpage>&#x2013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/j.polymer.2010.10.060</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yildirimer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Annabi</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Photocrosslinkable gelatin hydrogel for epidermal tissue engineering</article-title>. <source>Adv. Healthc. Mater. 7 janv</source> <volume>5</volume> (<issue>1</issue>), <fpage>108</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1002/adhm.201500005</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>P. X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Antibacterial and conductive injectable hydrogels based on quaternized chitosan-graft-polyaniline/oxidized dextran for tissue engineering</article-title>. <source>Acta Biomater.</source> <volume>26</volume>, <fpage>236</fpage>&#x2013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2015.08.006</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>